Latest News about CYTK
Recent news which mentions CYTK
33 Stocks Moving In Tuesday's Pre-Market Session
November 21, 2017
From Benzinga
20 Biggest Mid-Day Losers For Tuesday
May 09, 2017
From Benzinga
25 Stocks Moving In Tuesday's Pre-Market Session
May 09, 2017
From Benzinga
Why Cytokinetics, Inc. Jumped Higher Today
April 18, 2017
From Motley Fool
12 Biggest Mid-Day Gainers For Tuesday
April 18, 2017
From Benzinga
25 Stocks Moving In Tuesday's Pre-Market Session
April 18, 2017
From Benzinga
Cytokinetics Still A Buy After Phase 2 SMA Data
March 23, 2017
From Benzinga
18 Biggest Mid-Day Gainers For Wednesday
March 08, 2017
From Benzinga
Benzinga's Top Upgrades, Downgrades For March 8, 2017
March 08, 2017
From Benzinga
Benzinga's Top Upgrades, Downgrades For February 6, 2017
February 06, 2017
From Benzinga
Cytokinetics will sell percentage of royalties on heart failure drug for $90 million
February 01, 2017
From MarketWatch
6 Stocks Analysts Forecast The Largest Year-Over-Year Revenue Declines
December 27, 2016
From Benzinga
3 Small Biotech Stocks That Big Biotechs Like
December 18, 2016
From Motley Fool
20 Biggest Mid-Day Gainers For Friday
October 28, 2016
From Benzinga
12 Biggest Mid-Day Losers For Thursday
September 01, 2016
From Benzinga
Cytokinetics Presents Exploratory Analyses of Data from Phase 3 Clinical Trial of Dexpramipexole in Patients with ALS
January 10, 2016
Tickers
CYTK
From Benzinga
Markets plunge over possible rate increase
November 09, 2015
Amgen, Cytokinetics Announce Late-Breaking Presentation of COSMIC-HF Trial at AHA Scientific Sessions 2015
November 08, 2015
From Benzinga
From Benzinga
Mid-Day Market Update: Dyax Jumps On Acquisition News; Endurance International Shares Dip
November 02, 2015
From Benzinga
Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure
October 27, 2015
From Benzinga
Mid-Day Market Update: Vince Holding Declines After CEO Resignation; Natural Health Trends Shares Surge
July 14, 2015
From Benzinga
From Benzinga
Morning Market Gainers
February 13, 2015
From Benzinga
Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update
December 31, 2014
From Benzinga
From Benzinga
Mid-Day Market Update: Meadowbrook Insurance Shares Jump On Acquisition News; Crude Oil Drops Over 2%
December 31, 2014
From Benzinga
Cytokinetics Surges Amid Roth Capital Raising Its Price Target
December 31, 2014
Tickers
CYTK
From Benzinga
Biotech Stocks Make Big Moves In Final Days Of 2014
December 31, 2014
From Benzinga
Price target lifted on Cytokinetics
December 31, 2014
Tickers
CYTK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.